ICU MEDICAL INC/DE

For the period ended Mar 31, 2025. Filed May 8, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

ICUI$182.11+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets at and

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data and treasury shares)

March 31,2025 · December 31,2024
	(Unaudited)	(1)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$289,704		$308,566
Accounts receivable, net of allowance for doubtful accounts $13,403 at March 31, 2025 and $12,977 at December 31, 2024	170,928		182,828
Inventories	590,326		584,676
Prepaid income taxes	11,471		11,244
Prepaid expenses and other current assets	75,364		70,287
Assets held for sale	286,122		284,382
TOTAL CURRENT ASSETS	1,423,915		1,441,983
PROPERTY, PLANT AND EQUIPMENT, net	441,983		442,746
OPERATING LEASE RIGHT-OF-USE ASSETS	58,025		53,295
GOODWILL	1,455,113		1,432,772
INTANGIBLE ASSETS, net	716,667		740,789
DEFERRED INCOME TAXES	24,247		24,211
OTHER ASSETS	64,631		68,135
TOTAL ASSETS	$4,184,581		$4,203,931
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$180,409		$148,020
Accrued liabilities	278,892		306,923
Current portion of long-term debt	47,813		51,000
Income tax payable	12,246		17,328
Liabilities held for sale	29,664		32,911
TOTAL CURRENT LIABILITIES	549,024		556,182
LONG-TERM DEBT	1,488,565		1,531,858
OTHER LONG-TERM LIABILITIES	77,637		66,745
DEFERRED INCOME TAXES	45,493		48,814
INCOME TAX LIABILITY	36,173		35,097
COMMITMENTS AND CONTINGENCIES (Note 20)
STOCKHOLDERS’ EQUITY:
Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none	—		—
Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,611 shares at March 31, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,611 shares at March 31, 2025 and 24,517 shares at December 31, 2024	2,461		2,452
Additional paid-in capital	1,416,001		1,412,118
Treasury stock, at cost (420 shares at March 31, 2025 and 571 shares at December 31, 2024)	(60)		(92)
Retained earnings	674,682		690,158
Accumulated other comprehensive loss	(105,395)		(139,401)
TOTAL STOCKHOLDERS' EQUITY	1,987,689		1,965,235
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$4,184,581		$4,203,931

(1)December 31, 2024 balances were derived from audited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.